Tim Sauer

机构：Heidelberg University, University Hospital Heidelberg, Heidelberg University of Education, Heidelberg University · ORCID：0000-0001-5412-324X

发表论文 274 篇 · 总被引 3256 次 · h-index 30

代表论文

• Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML (2026 · Cell stem cell · 被引 4)
• Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial (2026 · Annals of Hematology · 被引 2)
• Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment (2026 · Cancer Cell · 被引 1)
• Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations (2026 · Transplantation and Cellular Therapy · 被引 1)
• IDH3 regulates citrate homeostasis to control metabolic fitness and venetoclax resistance of AML stem cells (2026 · Blood)
• Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia (2026 · Leukemia)